(Q50119529)

25 February 2018

title

Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission. (English)

1 reference

25 February 2018

main subject

prevention of HIV/AIDS

0 references

1 reference

1 reference

7

1 reference

25 February 2018

author name string

E G Lyall

1

1 reference

25 February 2018

M Blott

2

1 reference

25 February 2018

A de Ruiter

3

1 reference

25 February 2018

D Hawkins

4

1 reference

25 February 2018

D Mercy

5

1 reference

25 February 2018

Z Mitchla

6

1 reference

25 February 2018

S O'Shea

8

1 reference

25 February 2018

J R Smith

9

1 reference

25 February 2018

J Sunderland

10

1 reference

25 February 2018

R Webb

11

1 reference

25 February 2018

G P Taylor

12

1 reference

25 February 2018

British HIV Association

13

1 reference

25 February 2018

publication date

1 October 2001

1 reference

25 February 2018

published in

HIV Medicine

1 reference

25 February 2018

volume

2

1 reference

25 February 2018

issue

4

1 reference

25 February 2018

page(s)

314-334

1 reference

25 February 2018

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Risk of human immunodeficiency virus type 1 transmission through breastfeeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Natural conception in HIV-negative women with HIV-infected partners

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Insemination of HIV-negative women with processed semen of HIV-positive partners

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Pregnancy following intracytoplasmic sperm injection from an HIV-1-seropositive man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Infertility management in HIV positive couples: a dilemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

HIV and infertility: time to treat. There's no justification for denying treatment to parents who are HIV positive.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Demographic, clinical and social factors associated with human immunodeficiency virus infection and other sexually transmitted diseases in a cohort of women from the United Kingdom and Ireland. MRC Collaborative Study of women with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Intrauterine infection and preterm delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

The Ariel Project: A prospective cohort study of maternal-child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Association between Bacterial Vaginosis and Preterm Delivery of a Low-Birth-Weight Infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Activation of human immunodeficiency virus type 1 expression by Gardnerella vaginalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Induction of human immunodeficiency virus type 1 expression by anaerobes associated with bacterial vaginosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus. An application of the Bradford Hill criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Côte d'Ivoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Correlation between human immunodeficiency virus type 1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Treatment of cervicitis is associated with decreased cervical shedding of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission. Bangkok Collaborative Perinatal HIV Transmission Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

National surveillance of HIV-1 subtypes for England and Wales: design, methods, and initial findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Impact of HIV type 1 subtype variation on viral RNA quantitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Reduced antiretroviral drug susceptibility among patients with primary HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

HIV-1 drug resistance in newly infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Detection of drug resistance associated mutations in HIV primary infection within the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting. The EuroGUidelines Group for HIV resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

After AIDS clinical trial 076: the changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. Women and Infants Tran

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus-1 transmission in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinical Trials Group Protocol 076.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Codon 215 mutations in human immunodeficiency virus-infected pregnant women. Swiss Collaborative 'HIV and Pregnancy' Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Combination antiretroviral therapy and duration of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Antiretroviral therapy in pregnancy: a focus on safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Experience of nevirapine use in a London cohort of HIV-infected pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Is first trimester exposure to the combination of antiretroviral therapy and folate antagonists a risk factor for congenital abnormalities?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Mechanisms and timing of mother-to-child transmission of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

The cost-effectiveness of elective Cesarean delivery for HIV-infected women with detectable HIV RNA during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Nevirapine: pharmacokinetic considerations in children and pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Initial multicenter experience with double nucleoside therapy for human immunodeficiency virus infection during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

A meta-analytic evaluation of the polymerase chain reaction for the diagnosis of HIV infection in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Pneumocystis carinii pneumonia and cytomegalovirus infection in children with vertically acquired HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Method of feeding and transmission of HIV-1 from mothers to children by 15 months of age: prospective cohort study from Durban, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

Antiretroviral therapy for HIV-2 infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-2662.2001.00082.X

10.1046/J.1464-2662.2001.00082.X

21 January 2018

Identifiers

DOI

1 reference

25 February 2018

1 reference

25 February 2018